One confirmed case of Marburg virus disease has been identified in Uganda as of June 30, 2026, detected through systematic testing of all suspected viral haemorrhagic fever cases. This single case represents the nation’s first laboratory-confirmed Marburg diagnosis in 2026 and was identified via routine surveillance protocols rather than passive reporting. The case involved an 18-month-old girl whose initial clinical presentation suggested Ebola, but definitive laboratory testing revealed Marburg virus, highlighting the essential role of rapid, accurate diagnostic confirmation in outbreak management.
Early laboratory confirmation is critical for outbreak control, enabling public health authorities to implement appropriate containment measures and resource allocation. Uganda’s ability to detect and differentiate between viral haemorrhagic fever pathogens demonstrates the value of established surveillance infrastructure and systematic testing protocols. With WHO response teams now deployed across the country, ongoing monitoring and rapid identification of additional suspected cases will be essential for containing this emerging threat alongside existing outbreak response efforts.
Read the full article on GMJ Newsroom.
Was this article helpful?
GMJ Brief · Key Finding
📰 Read the full article: Uganda Confirms First Marburg Case Amid Ongoing Ebola Outbreak →
